# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001178913-21-003475
Filing Date
2021-11-10
Accepted
2021-11-10 17:06:21
Documents
41
Period of Report
2021-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8k.htm iXBRL | 8-K | 33826
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 52887
7 |  | exhibit_99-1slide1.jpg | GRAPHIC | 62640
8 |  | exhibit_99-1slide2.jpg | GRAPHIC | 344670
9 |  | exhibit_99-1slide3.jpg | GRAPHIC | 175216
10 |  | exhibit_99-1slide4.jpg | GRAPHIC | 164657
11 |  | exhibit_99-1slide5.jpg | GRAPHIC | 161568
12 |  | exhibit_99-1slide6.jpg | GRAPHIC | 104012
13 |  | exhibit_99-1slide7.jpg | GRAPHIC | 150919
14 |  | exhibit_99-1slide8.jpg | GRAPHIC | 121425
15 |  | exhibit_99-1slide9.jpg | GRAPHIC | 195036
16 |  | exhibit_99-1slide10.jpg | GRAPHIC | 160121
17 |  | exhibit_99-1slide11.jpg | GRAPHIC | 129467
18 |  | exhibit_99-1slide12.jpg | GRAPHIC | 137481
19 |  | exhibit_99-1slide13.jpg | GRAPHIC | 67473
20 |  | exhibit_99-1slide14.jpg | GRAPHIC | 166191
21 |  | exhibit_99-1slide15.jpg | GRAPHIC | 169609
22 |  | exhibit_99-1slide16.jpg | GRAPHIC | 117209
23 |  | exhibit_99-1slide17.jpg | GRAPHIC | 170233
24 |  | exhibit_99-1slide18.jpg | GRAPHIC | 160905
25 |  | exhibit_99-1slide19.jpg | GRAPHIC | 63500
26 |  | exhibit_99-1slide20.jpg | GRAPHIC | 155144
27 |  | exhibit_99-1slide21.jpg | GRAPHIC | 169765
28 |  | exhibit_99-1slide22.jpg | GRAPHIC | 144153
29 |  | exhibit_99-1slide23.jpg | GRAPHIC | 132120
30 |  | exhibit_99-1slide24.jpg | GRAPHIC | 183807
31 |  | exhibit_99-1slide25.jpg | GRAPHIC | 122562
32 |  | exhibit_99-1slide26.jpg | GRAPHIC | 144570
33 |  | exhibit_99-1slide27.jpg | GRAPHIC | 38847
| Complete submission text file | 0001178913-21-003475.txt |  | 5675472

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cmmb-20211110.xsd | EX-101.SCH | 4701
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cmmb-20211110_def.xml | EX-101.DEF | 18329
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cmmb-20211110_lab.xml | EX-101.LAB | 28549
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cmmb-20211110_pre.xml | EX-101.PRE | 20565
34 | EXTRACTED XBRL INSTANCE DOCUMENT | form8k_htm.xml | XML | 6623

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 211397695
SIC: 2834 Pharmaceutical Preparations